VR Logo

Aspira Pathlab & Diagnostics: Financial Results For The Quarter Ended June 30 2022


Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) this is to inform that Board of Directors of the Company in their meeting held today i.e. August 13 2022 has inter-alia considered and approved the unaudited Financial Results for the quarter ended on June 30 2022.

Click here to view PDF